Related Experiment Videos
Gout and the Risk of Non-vertebral Fracture
Seoyoung C Kim1,2, Julie M Paik3,4, Jun Liu1
1Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA.
Insights
This study found that gout patients do not have an increased risk of non-vertebral fractures. Elevated serum uric acid levels in gout patients were also not linked to higher fracture risk.
Area of Science:
- Rheumatology
- Orthopedics
- Epidemiology
Background:
- Osteoporosis is linked to inflammation and cytokines like IL-1 and IL-6.
- The relationship between hyperuricemia and osteoporosis is debated.
- The impact of gout on fracture risk is not well understood.
Purpose of the Study:
- To investigate the association between gout and non-vertebral fracture risk.
- To examine the role of serum uric acid levels in fracture risk among gout patients.
Main Methods:
- A retrospective cohort study using US commercial health plan data (2004-2013).
- Identified 73,202 gout patients and 219,606 non-gout patients.
- Used Cox proportional hazards models to compare fracture risk, adjusting for over 40 risk factors.
Main Results:
- Gout patients showed no increased risk of non-vertebral fractures (HR 0.98, 95% CI 0.85-1.12).
- Hip fracture risk was also not significantly higher in gout patients (HR 0.83, 95% CI 0.65-1.07).
- Baseline serum uric acid levels were not associated with non-vertebral fracture risk in gout patients (HR 1.03, 95% CI 0.93-1.15).
Conclusions:
- Gout is not associated with an increased risk of non-vertebral fractures.
- Serum uric acid levels do not appear to influence non-vertebral fracture risk in individuals with gout.
Abstract:
Prior studies suggest an association between osteoporosis, systemic inflammation, and pro-inflammatory cytokines such as interleukin (IL)-1 and IL-6. Conflicting findings exist on the association between hyperuricemia and osteoporosis. Furthermore, it remains unknown whether gout, a common inflammatory arthritis, affects fracture risk. Using data from a US commercial health plan (2004-2013), we evaluated the risk of non-vertebral fracture (ie, forearm, wrist, hip, and pelvis) in patients with gout versus those without. Gout patients were identified with ≥2 diagnosis codes and ≥1 dispensing for a gout-related drug. Non-gout patients, identified with ≥2 visits coded for any diagnosis and ≥1 dispensing for any prescription drugs, were free of gout diagnosis and received no gout-related drugs. Hip fracture was the secondary outcome. Fractures were identified with a combination of diagnosis and procedure codes. Cox proportional hazards models compared the risk of non-vertebral fracture in gout patients versus non-gout, adjusting for more than 40 risk factors for osteoporotic fracture. Among gout patients with baseline serum uric acid (sUA) measurements available, we assessed the risk of non-vertebral fracture associated with sUA. We identified 73,202 gout and 219,606 non-gout patients, matched on age, sex, and the date of study entry. The mean age was 60 years and 82% were men. Over the mean 2-year follow-up, the incidence rate of non-vertebral fracture per 1,000 person-years was 2.92 in gout and 2.66 in non-gout. The adjusted hazard ratio (HR) was 0.98 (95% confidence interval [CI] 0.85-1.12) for non-vertebral fracture and 0.83 (95% CI 0.65-1.07) for hip fracture in gout versus non-gout. Subgroup analysis (n = 15,079) showed no association between baseline sUA and non-vertebral fracture (HR = 1.03, 95% CI 0.93-1.15), adjusted for age, sex, comorbidity score, and number of any prescription drugs. Gout was not associated with a risk of non-vertebral fracture. Among patients with gout, sUA was not associated with the risk of non-vertebral fracture. © 2016 American Society for Bone and Mineral Research.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Nursing Assessment of the Genitourinary System I: Health History
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi III: Medical Management